Research Paper Volume 13, Issue 6 pp 8975—8988
PARP inhibitors in breast and ovarian cancer with BRCA mutations: a meta-analysis of survival
Figure 2. PFS of breast or ovarian cancer patients with BRCAm treated with PARPis.
Figure 2. PFS of breast or ovarian cancer patients with BRCAm treated with PARPis.